...

 
Cannvas.Me
Sign Up For Free
Interim director of the MSU Center for Research on Ingredient Safety Norbert Kaminski, has begun a yearlong preclinical study exploring cannabis compounds and their ability to slow the progress of Parkinson’s, Alzheimer’s and other brain diseases. 

The Michigan State University researcher will focus on the safety and effectiveness of these compounds by testing human white blood cells and evaluating the effects the compounds have on the immune system. 

Kaminski is also the director of the MSU Institute for Integrative Toxicology and a professor in the Department of Pharmacology and Toxicology. In an earlier study, he demonstrated a relationship between cannabis use and improved brain health in HIV/AIDS patients compared to patients who did not use cannabis. 

Kaminski began the study earlier in the summer and is working in cooperation with Las-Vegas based GB Sciences Inc. which owns the compounds being tested. 

Source: https://msutoday.msu.edu/news/2018/new-study-explores-the-role-cannabis-plays-in-treating-parkinsons-alzheimers/

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close